Skip to main content
Camlin Fine Sciences Ltd logo

Camlin Fine Sciences Ltd — Investor Relations & Filings

Ticker · CAMLINFINE ISIN · INE052I01032 LEI · 3358005CR8R9MY6DLY36 BSE.NS Manufacturing
Open in API
Filings indexed 1,525 across all filing types
Latest filing 2019-08-02 Regulatory Filings
Country IN India
Listing BSE.NS CAMLINFINE

About Camlin Fine Sciences Ltd

https://www.camlinfs.com

Camlin Fine Sciences Ltd is a global provider of specialty chemicals, specializing in shelf-life extension solutions and aroma ingredients. The company is a leading manufacturer of traditional antioxidants, including Tertiary Butylhydroquinone (TBHQ) and Butylated Hydroxyanisole (BHA), which are utilized to maintain the stability and quality of food, feed, and industrial applications. Its product portfolio also features aroma chemicals such as vanillin and ethyl vanillin, supported by a vertically integrated manufacturing process. Camlin Fine Sciences serves a broad range of sectors, including human nutrition, animal health, pet food, pharmaceuticals, and fragrances. By utilizing advanced chemical synthesis and a global distribution network, the company delivers performance chemicals and customized blends designed to enhance product longevity and sensory characteristics.

Recent filings

Filing Released Lang Actions
Investor Call
Regulatory Filings
2019-08-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 2nd August 2019 informing stock exchanges about a scheduled conference call on 5th August 2019 to discuss the financial results for the quarter ended 30th June 2019 (Q1). It includes dial-in details and participant names but does not contain any financial data or analysis itself. The document is an announcement of a conference call related to quarterly results, not the transcript or the financial report itself. According to the rules, such announcements are classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the actual call transcript.
2019-08-02 English
Shareholders meeting
AGM Information Classification · 95% confidence The document contains a list of resolutions typically proposed and voted on during a company's Annual General Meeting (AGM). It includes ordinary business items such as adoption of audited financial statements for the financial year ended 31st March 2019, appointment and re-appointment of directors, appointment of an independent non-executive director, approval of related party transactions, and payment of remuneration to a chairman. The document also mentions voting methods (e-voting, voting by ballot paper) and submission of voting results to stock exchanges within 48 hours of the meeting's conclusion. The content is consistent with AGM materials, specifically the information shared during the AGM regarding resolutions and voting results. The document length is under 5,000 characters and does not contain full financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a voting results declaration document because it states that results will be submitted later, indicating it is the AGM information itself. Therefore, the best classification is AGM Information (AGM-R).
2019-08-02 English
Outcome of Board Meeting
Regulatory Filings
2019-08-02 English
Proceeding of the 26th Annual General Meeting
Regulatory Filings
2019-08-02 English
Outcome of Board Meeting
Regulatory Filings
2019-08-02 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.